Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype-Reference-Cited by-同舟云学术

Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype

Published:2022-08-16 Issue:3 Volume:195 Page:431-439
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Zang Fan,Ding Xinyun,Chen Jiuan,Hu Li,Sun Jie,Zhang Juan,Xu Ye,Yao Lu^ORCID,Xie Yuntao^ORCID

Funder

Beijing Municipal Administration of Hospitals

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06702-4.pdf

Reference34 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 71(3):209–249. https://doi.org/10.3322/caac.21660

2. Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE (2014) Breast cancer in China. Lancet Oncol 15(7):e279-289. https://doi.org/10.1016/S1470-2045(13)70567-9

3. Yao L, Sun J, Zhang J, He Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B et al (2016) Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. Breast Cancer Res Treat 156(3):441–445. https://doi.org/10.1007/s10549-016-3766-3

4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66–71. https://doi.org/10.1126/science.7545954

5. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265(5181):2088–2090. https://doi.org/10.1126/science.8091231

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis;Therapeutic Advances in Medical Oncology;2024-01

2. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients;npj Breast Cancer;2023-11-30

3. Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan;Breast Cancer Research and Treatment;2023-08-01

4. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden;JAMA Network Open;2023-06-13

5. A global perspective on the ethnic-specific BRCA variation and its implication in clinical application;Journal of the National Cancer Center;2023-03